首页> 外文期刊>International immunopharmacology >Prope tolerance-the future of organ transplantation from the laboratory to the clinic.
【24h】

Prope tolerance-the future of organ transplantation from the laboratory to the clinic.

机译:支持耐受性-从实验室到临床器官移植的未来。

获取原文
获取原文并翻译 | 示例
           

摘要

This is a short review of tolerance from the point of view of the clinician. Various examples of tolerance occurring in patients and animal models that relate to the clinical experience are described. It is suggested that there may be different mechanisms by which tolerance is achieved, but, from the patient's point of view operational, tolerance is the goal whereby, after a short induction procedure, the patient will maintain good function in the grafted organ indefinitely without maintenance immunosuppression. It is pointed out that such a goal may be difficult to achieve with any given protocol due to the enormous variation between donors and recipients of organ grafts of tissue matching, innate immune reactivity, and susceptibility to disturbance of a tolerant state by infections or allergic reactions. Thus, the case is made for prope or almost tolerance in which graft acceptance is maintained by a low, nontoxic dosage of maintenance immunosuppression which may not be required indefinitely.
机译:从临床医生的角度来看,这是对耐受性的简短回顾。描述了与临床经验有关的患者和动物模型中出现的耐受性的各种实例。建议可能存在不同的机制来实现耐受性,但是,从患者的操作角度来看,耐受性是目标,即在短暂的诱导过程后,患者将无限期地保持良好的功能,而无需维持免疫抑制。需要指出的是,由于给定的组织匹配的器官移植的供体和受体之间存在巨大差异,先天免疫反应性以及易受感染或过敏反应影响的耐受状态的敏感性,因此使用任何给定的方案都可能难以实现这一目标。 。因此,可以通过适当的低或无毒剂量维持免疫抑制来维持移植物接受或接受,这是无限期的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号